Equities
Health CarePharmaceuticals and Biotechnology
  • Price (EUR)44.75
  • Today's Change0.65 / 1.47%
  • Shares traded429.00
  • 1 Year change+22.60%
  • Beta--
Data delayed at least 15 minutes, as of Nov 22 2024 11:04 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Income statement Back to Overview

In millions of EUR
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
REVENUE AND GROSS PROFIT
Total revenue1,1901,3411,041
OPERATING EXPENSES
Cost of revenue total532492448
Selling, general and admin. expenses, total284264224
Depreciation/amortization191918
Unusual expense(income)(38)0(3.4)
Other operating expenses, total(5.4)(4.4)(2.8)
Total operating expense915901798
Operating income275440243
Other, net(0.5)(0.3)(0.3)
INCOME TAXES, MINORITY INTEREST AND EXTRA ITEMS
Net income before taxes272440242
Provision for income taxes559149
Net income after taxes217350194
Minority interest------
Net income before extra. Items217350194
Total extraordinary items------
Net income217350194
Inc.avail. to common excl. extra. Items217350194
Inc.avail. to common incl. extra. Items217350194
EPS RECONCILIATION
Basic/primary weighted average shares140141141
Basic/primary eps excl. extra items1.542.491.38
Basic/primary eps incl. extra items1.542.491.38
Dilution adjustment------
Diluted weighted average shares140141141
Diluted eps excl. extra items1.542.491.38
Diluted eps incl. extra items1.542.491.38
COMMON STOCK DIVIDENDS
DPS - common stock primary issue1.621.601.50
Gross dividend - common stock--224211
PRO FORMA INCOME
Pro forma net income------
Interest expense, supplemental5.201.501.00
SUPPLEMENTAL INCOME
Depreciation, supplemental444139
Total special items(38)0(3.4)
NORMALISED INCOME
Normalized income before taxes234440239
Effect of special items on income taxes(7.62)0(0.68)
Income tax excluding impact of special items479148
Normalized income after tax187350191
Normalized income avail. to common187350191
Basic normalized EPS1.332.491.36
Diluted normalized EPS1.332.491.36
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.